Good news for advanced therapies, bad news for an old painkiller
This article was originally published in Scrip
Executive Summary
It's been a busy week for the European Medicines Agency. Not only has it recommended marketing approval of the first advanced therapy product under the new regulatory framework, it has also finally decided that all drugs containing the opioid painkiller dextropropoxyphene should be withdrawn for safety reasons.